Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents

  • Morales Jiménez, Amanda
  • Cruz, Alejandro
  • Pérez-Sánchez, Álex|||0000-0003-3636-3885
  • D'Avino, Danilo
  • Galassi, Gaia
  • Milano, Erica Ginevra
  • Bernareggi, Irene
  • Arenós-Bach, Carla|||0009-0002-0297-539X
  • Grazioso, Giovanni
  • Alibés, Ramon|||0000-0002-7997-2691
  • Hernando, Jordi|||0000-0002-1126-4138
  • Gorostiza, Pau|||0000-0002-7268-5577
  • Rossi, Antonietta
  • Pistocchi, Anna
  • Matera, Carlo|||0000-0001-6939-3859
  • Busqué, Félix|||0000-0001-7566-4264
  • González Lafont, Àngels|||0000-0003-0729-2483
  • Lluch, José M.|||0000-0002-7536-1869
Despite their extensive use, the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) remains significantly constrained by adverse side effects. This limitation primarily arises from insufficient selectivity, as current NSAIDs inhibit not only the inducible cyclooxygenase-2 (COX-2) isoform at sites of inflammation but also constitutive COX-2 in healthy tissues and, frequently, cyclooxygenase-1. To address this challenge, we developed photoswitchable NSAIDs that combine COX-2 selectivity with light-controlled activity to enable spatiotemporal confinement of the therapeutic effect at inflamed tissues. Following computational design and screening of a library of azoaromatic derivatives of celecoxib─the most widely used COX-2 selective NSAID─three photoswitchable analogues were synthesized, which exhibited reversible and efficient trans-cis photoconversion. Light-controlled and selective COX-2 inhibition was demonstrated for these compounds in vitro, reaching up to 5-fold potency enhancement in macrophage assays upon photoisomerization from the initial, dark-adapted trans isomer to the cis state. The best candidate displayed in vivo efficacy in a zebrafish model of acute inflammation, where administration of the photoinduced cis form reduced leukocyte recruitment at the wound site. These findings position photoswitchable NSAIDs as a promising alternative to conventional drugs for treating inflammation and related conditions, including cancer.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Brain state identification and neuromodulation to promote recovery of consciousness

  • Van Der Lande, Glenn J. M.
  • Casas-Torremocha, Diana
  • Manasanch, Arnau
  • Dalla Porta, Leonardo
  • Gosseries, Olivia
  • Alnagger, Naji
  • Barra, Alice
  • Mejias, Jorge F.
  • Panda, Rajanikant
  • Riefolo, Fabio
  • Thibaut, Aurore
  • Bonhomme, Vincent
  • Thirion, Bertrand
  • Clasca, Francisco
  • Gorostiza, Pau
  • Sanchez-Vives, Maria V.
  • Deco, Gustavo
  • Laureys, Steven
  • Zamora-López, Gorka
  • Annen, Jitka
Experimental and clinical studies of consciousness identify brain states (i.e. quasi-stable functional cerebral organization) in a non-systematic manner and largely independent of the research into brain state modulation. In this narrative review, we synthesize advances in the identification of brain states associated with consciousness in animal models and physiological (sleep), pharmacological (anaesthesia) and pathological (disorders of consciousness) states of altered consciousness in humans. We show that in reduced consciousness the frequencies in which the brain operates are slowed down and that the pattern of functional communication is sparser, less efficient, and less complex. The results also highlight damaged resting-state networks, in particular the default mode network, decreased connectivity in long-range connections and especially in the thalamocortical loops. Next, we show that therapeutic approaches to treat disorders of consciousness, through pharmacology (e.g. amantadine, zolpidem), and (non-) invasive brain stimulation (e.g. transcranial direct current stimulation, deep brain stimulation) have shown partial effectiveness in promoting consciousness recovery. Although some features of conscious brain states may improve in response to neuromodulation, targeting often remains non-specific and does not always lead to (behavioural) improvements. The fields of brain state identification and neuromodulation of brain states in relation to consciousness are showing fascinating developments that, when integrated, might propel the development of new and better-targeted techniques for disorders of consciousness. We here propose a therapeutic framework for the identification and modulation of brain states to facilitate the interaction between the two fields. We propose that brain states should be identified in a predictive setting, followed by theoretical and empirical testing (i.e. in animal models, under anaesthesia and in patients with a disorder of consciousness) of neuromodulation techniques to promote consciousness in line with such predictions. This framework further helps to identify where challenges and opportunities lay for the maturation of brain state research in the context of states of consciousness. It will become apparent that one angle of opportunity is provided through the addition of computational modelling. Finally, it aids in recognizing possibilities and obstacles for the clinical translation of these diagnostic techniques and neuromodulation treatment options across both the multimodal and multi-species approaches outlined throughout the review., NA is research fellow, OG and AT are Research Associates, and SL is the research director at Fonds de la Recherche Scientifique (FRS-FNRS). JA is a postdoctoral fellow at the Fonds voor Wetenschappelijk Onderzoek (FWO) (1265522N). The study was further supported by the University and University Hospital of Liège, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the FNRS PDR project (T.0134.21), the ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project), the fund Generet, the King Baudouin Foundation, the Télévie Foundation, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PROgramme de Développement d'Expériences scientifiques (PRODEX Programme), the Public Utility Foundation `Université Européenne du Travail', `Fondazione Europea di Ricerca Biomedica', the BIAL Foundation, the Mind Science Foundation, the European Commission, the Fondation Leon Fredericq, the Mind-Care foundation, the DOCMA project (EU-H2020-MSCA-RISE-778234), the National Natural Science Foundation of China (Joint Research Project 81471100) and the European Foundation of Biomedical Research (FERB Onlus). EU grants ICT-36-2020-101016787 (DEEPER), EIC Pathfinder GAP-101130883 (PHOTOTHERAPORT), and -EIC-2023-PATHFINDEROPEN-101130650 (META-BRAIN), Government of Catalonia AGAUR [Centres de Recerca de Catalunya (CERCA) Programme, 2021-SGR-01410; AGAUR 2021-SGR-01165 - NEUROVIRTUAL], Ministerio de Ciencia e Innovación (MICINN) grants PID2019-111493RB-I00 (DEEP RED) and PID2022- 142609OB-I00 (EPILLUM), PID2020-112947RB-I00 financed by Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)/10.13039/501100011033 (CORTICOMOD), and Fundaluce and 'la Caixa' foundations (ID 100010434, agreement LCF/PR/HR19/52160010).
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Reversible photocontrol of dopaminergic transmission in wild-type animals

  • Matera, Carlo
  • Calvé, Pablo
  • Casadó Anguera, Verònica
  • Sortino, Rosalba
  • Gomila, Alexandre M. J.
  • Moreno Guillén, Estefanía
  • Gener, Thomas
  • Delgado-Sallent, Cristina
  • Nebot, Pau
  • Costazza, Davide
  • Conde-Berriozábal, Sara
  • Masana Nadal, Mercè
  • Hernando, Jordi
  • Casadó, Vicent
  • Puig, M. Victoria
  • Gorostiza Langa, Pablo Ignacio
Understanding the dopaminergic system is a priority in neurobiology and neuropharmacology. Dopamine receptors are involved in the modulation of fundamental physiological functions and dysregulation of dopaminergic transmission is associated with major neurological disorders. However, the available tools to dissect the endogenous dopaminergic circuits have limited specificity, reversibility, resolution, or require genetic manipulation. Here we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control of dopaminergic transmission. We demonstrate that azodopa activates D1-like receptors in vitro in a light-dependent manner. Moreover, it enables reversibly photocontrolling zebrafish motility on a time scale of seconds and allows separating the retinal component of dopaminergic neurotransmission. Azodopa increases the overall neural activity in the cortex of anesthetized mice and displays illuminationdependent activity in individual cells. Azodopa is the first photoswitchable dopamine agonist with demonstrated efficacy in wildtype animals and opens the way to remotely controlling dopaminergic neurotransmission for fundamental and therapeutic purposes.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Subunit-specific photocontrol of glycine receptors by azobenzene-nitrazepam photoswitcher

  • Maleeva, Galyna
  • König, Burkhard
  • Gorostiza Langa, Pablo Ignacio
  • Nin Hill, Alba
  • Rustler, Karin
  • Petukhova, Elena
  • Ponomareva, Daria
  • Gomila Juaneda, Alexandre
  • Wutz, Daniel
  • Bregestovski, Piotr
  • Alfonso Prieto, Mercedes
© 2021 Maleeva et al. Photopharmacology is a unique approach that through a combination of photochemistry methods and advanced life science techniques allows the study and control of specific biological processes, ranging from intracellular pathways to brain circuits. Recently, a first photochromic channel blocker of anion-selective GABAA receptors, the azobenzene-nitrazepam-based photochromic compound (Azo-NZ1), has been described. In the present study, using patch-clamp technique in heterologous system and in mice brain slices, site-directed mutagenesis and molecular modeling we provide evidence of the interaction of Azo-NZ1 with glycine receptors (GlyRs) and determine the molecular basis of this interaction. Glycinergic synaptic neurotransmission determines an important inhibitory drive in the vertebrate nervous system and plays a crucial role in the control of neuronal circuits in the spinal cord and brain stem. GlyRs are involved in locomotion, pain sensation, breathing, and auditory function, as well as in the development of such disorders as hyperekplexia, epilepsy, and autism. Here, we demonstrate that Azo-NZ1 blocks in a UV-dependent manner the activity of a2 GlyRs (GlyR2), while being barely active on a1 GlyRs (GlyR1). The site of Azo-NZ1 action is in the chloride-selective pore of GlyR at the 2’ position of transmembrane helix 2 and amino acids forming this site determine the difference in Azo-NZ1 blocking activity between GlyR2 and GlyR1. This subunit-specific modulation is also shown on motoneurons of brainstem slices from neonatal mice that switch during development from expressing “fetal” GlyR2 to “adult” GlyR1 receptors.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Plasmonics on a Neural Implant: Engineering Light–Matter Interactions on the Nonplanar Surface of Tapered Optical Fibers

  • Pisano, F.
  • Kashif, M.F
  • Balena, Antonio
  • Pisanello, M.
  • De Angelis, F.
  • Menéndez de la Prida, Liset
  • Valiente, Manuel
  • D'Orazio, A.
  • De Vittorio, M.
  • Grande, M.
  • Pisanello, F.
Optical methods are driving a revolution in neuroscience. Ignited by optogenetic techniques, a set of strategies has emerged to control and monitor neural activity in deep brain regions using implantable photonic probes. A yet unexplored technological leap is exploiting nanoscale light-matter interactions for enhanced bio-sensing, beam-manipulation and opto-thermal heat delivery in the brain. To bridge this gap, we got inspired by the brain cells’ scale to propose a nano-patterned tapered-fiber neural implant featuring highly-curved plasmonic structures (30 μm radius of curvature, sub-50 nm gaps). We describe the nanofabrication process of the probes and characterize their optical properties. We suggest a theoretical framework using the interaction between the guided modes and plasmonic structures to engineer the electric field enhancement at arbitrary depths along the implant, in the visible/near-infrared range. We show that our probes can control the spectral and angular patterns of optical transmission, enhancing the angular emission and collection range beyond the reach of existing optical neural interfaces. Finally, we evaluate the application as fluorescence and Raman probes, with wave-vector selectivity, for multimodal neural applications. We believe our work represents a first step towards a new class of versatile nano-optical neural implants for brain research in health and disease., M.D.V., M.G., and Fe.P. jointly supervised and are co-last authors in this work. Fi.P., A.B., and Fe.P. acknowledge funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 677683. F.D.A., L.M.d.l.P., M.V., M.D.V., and Fe.P. acknowledge funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 828972. Fi.P., M.D.V., and Fe.P. acknowledge that this project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 101016787. M.P., Fe.P., and M.D.V. were funded by the U.S. National Institutes of Health (Grant No. 1UF1NS108177-01). Open access funding provided by Istituto Italiano di Tecnologia within the CRUI-CARE agreement
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Plasmonics on a Neural Implant: Engineering Light–Matter Interactions on the Nonplanar Surface of Tapered Optical Fibers

  • Pisano, F.
  • Kashif, M.F
  • Balena, Antonio
  • Pisanello, M.
  • De Angelis, F.
  • Menéndez de la Prida, Liset
  • Valiente, Manuel
  • D'Orazio, A.
  • De Vittorio, M.
  • Grande, M.
  • Pisanello, F.
Optical methods are driving a revolution in neuroscience. Ignited by optogenetic techniques, a set of strategies has emerged to control and monitor neural activity in deep brain regions using implantable photonic probes. A yet unexplored technological leap is exploiting nanoscale light-matter interactions for enhanced bio-sensing, beam-manipulation and opto-thermal heat delivery in the brain. To bridge this gap, we got inspired by the brain cells’ scale to propose a nano-patterned tapered-fiber neural implant featuring highly-curved plasmonic structures (30 μm radius of curvature, sub-50 nm gaps). We describe the nanofabrication process of the probes and characterize their optical properties. We suggest a theoretical framework using the interaction between the guided modes and plasmonic structures to engineer the electric field enhancement at arbitrary depths along the implant, in the visible/near-infrared range. We show that our probes can control the spectral and angular patterns of optical transmission, enhancing the angular emission and collection range beyond the reach of existing optical neural interfaces. Finally, we evaluate the application as fluorescence and Raman probes, with wave-vector selectivity, for multimodal neural applications. We believe our work represents a first step towards a new class of versatile nano-optical neural implants for brain research in health and disease., M.D.V., M.G., and Fe.P. jointly supervised and are co-last authors in this work. Fi.P., A.B., and Fe.P. acknowledge funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 677683. F.D.A., L.M.d.l.P., M.V., M.D.V., and Fe.P. acknowledge funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 828972. Fi.P., M.D.V., and Fe.P. acknowledge that this project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 101016787. M.P., Fe.P., and M.D.V. were funded by the U.S. National Institutes of Health (Grant No. 1UF1NS108177-01). Open access funding provided by Istituto Italiano di Tecnologia within the CRUI-CARE agreement
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ratiometric Nanothermometer Based on a Radical Excimer for In Vivo Sensing

  • Blasi, Davide
  • Gonzalez Pato, Nerea 
  • Rodríguez Rodríguez, Xavier
  • Díez Zabala, Íñigo
  • Srinivasan, Sumithra Y.
  • Camarero, Núria
  • Esquivias, Oriol
  • Roldán, Mònica
  • Guasch, Judit
  • Laromaine, Anna
  • Gorostiza, Pau
  • Veciana, Jaume
  • Ratera, Immaculada
Ratiometric fluorescent nanothermometers with near-infrared emission play an important role in in vivo sensing since they can be used as intracellular thermal sensing probes with high spatial resolution and high sensitivity, to investigate cellular functions of interest in diagnosis and therapy, where current approaches are not effective. Herein, the temperature-dependent fluorescence of organic nanoparticles is designed, synthesized, and studied based on the dual emission, generated by monomer and excimer species, of the tris(2,4,6-trichlorophenyl)methyl radical (TTM) doping organic nanoparticles (TTMd-ONPs), made of optically neutral tris(2,4,6-trichlorophenyl)methane (TTM-αH), acting as a matrix. The excimer emission intensity of TTMd-ONPs decreases with increasing temperatures whereas the monomer emission is almost independent and can be used as an internal reference. TTMd-ONPs show a great temperature sensitivity (3.4% K-1 at 328 K) and a wide temperature response at ambient conditions with excellent reversibility and high colloidal stability. In addition, TTMd-ONPs are not cytotoxic and their ratiometric outputs are unaffected by changes in the environment. Individual TTMd-ONPs are able to sense temperature changes at the nano-microscale. In vivo thermometry experiments in Caenorhabditis elegans (C. elegans) worms show that TTMd-ONPs can locally monitor internal body temperature changes with spatio-temporal resolution and high sensitivity, offering multiple applications in the biological nanothermometry field., D.B. and N.G.-P. contributed equally to this work. The authors are grateful for the financial support received from the Spanish Government (PID2020-115296RA-I00, PID2019-105622RB-I00, PDI2021-122645OB-I00, RTI2018-096273-B-I00 and PID2019-111493RB-I00) funded by MICIN and the “Ramón y Cajal” program (RYC-2017-22614), the Generalitat de Catalunya (SGR-918, 2017SGR765, SGR Cat 2021-00438, 2017-SGR-1442, and 2021-SGR-1410, 2021-SGR-00446), and the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN). DB gratefully acknoledges the REFIN (Return for Future Innovation) action for funding, an ininitiative co - funded by European Union through the POR Puglia 2014 - 2020 (ID grant: 2455F798). This research was also supported by the European Union's Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, grant agreement Nr. 754397), Human Brain Project WaveScaES (SGA2-785907 and SGA3-945539), DEEPER (ICT36-2020-101016787), and the Marie Skłodowka-Curie grant agreement Nr. 101007804 (Micro4Nano). Support from Fundaluce and CaixaHealth (ID 100010434) are also acknowledged. The work was supported as well by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany). ICMAB-CSIC acknowledges support from the Severo Ochoa Programme for Centres of Excellence in R&D (FUNFUTURE, CEX2019-000917-S). IBEC acknowledges support from the CERCA programme of AGAUR/Generalitat de Catalunya and the Severo Ochoa Programme. This work had been developed inside the “Biochemistry, Molecular Biology and Biomedicine” and “Materials Science” Ph.D. programs of UAB. Nerea Gonzalez-Pato acknowledges the financial support from the FPU fellowship (FPU17/02551) from the Spanish Ministry., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Toward Plasmonic Neural Probes: SERS Detection of Neurotransmitters through Gold-Nanoislands-Decorated Tapered Optical Fibers with Sub-10 nm Gaps

  • Zheng, D.
  • Pisano, F.
  • Collard, L.
  • Balena, Antonio
  • Pisanello, M.
  • Spagnolo, B.
  • Mach-Batlle, R.
  • Tantussi, F.
  • Carbone, L.
  • De Angelis, F.
  • Valiente, M.
  • Menéndez de la Prida, Liset
  • Ciracì, Cristian
  • De Vittorio, M.
  • Pisanello, F.
Integration of plasmonic nanostructures with fiber-optics-based neural probes enables label-free detection of molecular fingerprints via surface-enhanced Raman spectroscopy (SERS), and it represents a fascinating technological horizon to investigate brain function. However, developing neuroplasmonic probes that can interface with deep brain regions with minimal invasiveness while providing the sensitivity to detect biomolecular signatures in a physiological environment is challenging, in particular because the same waveguide must be employed for both delivering excitation light and collecting the resulting scattered photons. Here, a SERS-active neural probe based on a tapered optical fiber (TF) decorated with gold nanoislands (NIs) that can detect neurotransmitters down to the micromolar range is presented. To do this, a novel, nonplanar repeated dewetting technique to fabricate gold NIs with sub-10 nm gaps, uniformly distributed on the wide (square millimeter scale in surface area), highly curved surface of TF is developed. It is experimentally and numerically shown that the amplified broadband near-field enhancement of the high-density NIs layer allows for achieving a limit of detection in aqueous solution of 10 m for rhodamine 6G and 10 m for serotonin and dopamine through SERS at near-infrared wavelengths. The NIs-TF technology is envisioned as a first step toward the unexplored frontier of in vivo label-free plasmonic neural interfaces., M.D.V. and Fe.P. contributed equally to this work and are co-last-authors. D.Z., Li.C., R.M.-B., A.B., C.C., F.T., F.D.A., L.M.P., M.V., M.D.V., and Fe.P. acknowledge funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 828972. Fi.P., A.B., B.S., and Fe.P. acknowledge funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 677683. Lu.C. acknowledges financial support by the Italian Ministry of Economic Development through the Project “GENESI”-Development of innovative radiopharmaceuticals and biomarkers for the diagnosis of tumors of the male and female reproductive apparatus (cod. F/180003/01-03/X43, Call MISE “Intelligent Factory, Agri food and Life Sciences”). Fi.P., M.D.V., and Fe.P. acknowledge that this project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 101016787. M.P., Fe.P., and M.D.V. were funded by the U.S. National Institutes of Health (Grant No. 1UF1NS108177-01).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Vibrational fiber photometry: label-free and reporter-free minimally invasive Raman spectroscopy deep in the mouse brain

  • Pisano, Filippo
  • Masmudi-Martín, Mariam
  • Andriani, Maria Samuela
  • Cid, Elena
  • Kazemzadeh, Mohammadrahim
  • Pisanello, Marco
  • Balena, Antonio
  • Collard, Liam
  • Parras, Teresa Jurado
  • Bianco, Marco
  • Baena, Patricia
  • Tantussi, Francesco
  • Grande, Marco
  • Sileo, Leonardo
  • Gentile, Francesco
  • De Angelis, Francesco
  • De Vittorio, Massimo
  • Menéndez de la Prida, Liset
  • Valiente, Manuel
  • Pisanello, Ferruccio
Optical approaches to monitor neural activity are transforming neuroscience, owing to a fast-evolving palette of genetically encoded molecular reporters. However, the field still requires robust and label-free technologies to monitor the multifaceted biomolecular changes accompanying brain development, aging or disease. Here, we have developed vibrational fiber photometry as a low-invasive method for label-free monitoring of the biomolecular content of arbitrarily deep regions of the mouse brain in vivo through spontaneous Raman spectroscopy. Using a tapered fiber probe as thin as 1 µm at its tip, we elucidate the cytoarchitecture of the mouse brain, monitor molecular alterations caused by traumatic brain injury, as well as detect markers of brain metastasis with high accuracy. We view our approach, which introduces a deep learning algorithm to suppress probe background, as a promising complement to the existing palette of tools for the optical interrogation of neural function, with application to fundamental and preclinical investigations of the brain and other organs., This work is dedicated to the memory of Prof. Marco Grande and to his legacy of scientific excellence and human kindness. M.M.-M, E.C., T.J.P., A.B., F.T., L.C., M.D.V., F.D.A., L.M.P., M.V. and F. Pisanello acknowledge funding from the European Union’s Horizon 2020 FET-Open Programme project NANOBRIGHT under grant agreement 828972. F. Pisano, M.B., M.P., L.S., M.D.V. and F. Pisanello acknowledge funding from the European Union’s Horizon 2020 Research and Innovation Programme project DEEPER under grant agreement 101016787. This research received support from the European Community under the program Horizon 2020 project ProID under grant agreement 964363. F. Pisano acknowledges funding from PARD 2024 from the University of Padua. M.M.-M. acknowledges funding from a postdoctoral grant (2023) from the Scientific Foundation of the Spanish Association Against Cancer. F.G. acknowledges funding from Associazione Italiana per la Ricerca sul Cancro – AIRC IG 2021 ID 25656. L.C., M.D.V. and F. Pisanello acknowledge funding from the Project 'RAISE (Robotics and AI for Socio-economic Empowerment)' (code ECS00000035) funded by European Union – NextGenerationEU PNRR MUR – M4C2 – Investimento 1.5 – Avviso 'Ecosistemi dell’Innovazione' CUP J33C22001220001. A.B. acknowledges funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement (101106602)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Reversible photocontrol of dopaminergic transmission in wild-type animals

  • Matera, Carlo
  • Calvé, Pablo
  • Casadó Anguera, Verònica
  • Sortino, Rosalba
  • Gomila, Alexandre M. J.
  • Moreno Guillén, Estefanía
  • Gener, Thomas
  • Delgado-Sallent, Cristina
  • Nebot, Pau
  • Costazza, Davide
  • Conde-Berriozábal, Sara
  • Masana Nadal, Mercè
  • Hernando, Jordi
  • Casadó, Vicent
  • Puig, M. Victoria
  • Gorostiza Langa, Pablo Ignacio
Understanding the dopaminergic system is a priority in neurobiology and neuropharmacology. Dopamine receptors are involved in the modulation of fundamental physiological functions and dysregulation of dopaminergic transmission is associated with major neurological disorders. However, the available tools to dissect the endogenous dopaminergic circuits have limited specificity, reversibility, resolution, or require genetic manipulation. Here we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control of dopaminergic transmission. We demonstrate that azodopa activates D1-like receptors in vitro in a light-dependent manner. Moreover, it enables reversibly photocontrolling zebrafish motility on a time scale of seconds and allows separating the retinal component of dopaminergic neurotransmission. Azodopa increases the overall neural activity in the cortex of anesthetized mice and displays illuminationdependent activity in individual cells. Azodopa is the first photoswitchable dopamine agonist with demonstrated efficacy in wildtype animals and opens the way to remotely controlling dopaminergic neurotransmission for fundamental and therapeutic purposes.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Brain state identification and neuromodulation to promote recovery of consciousness

  • Van Der Lande, Glenn J. M.
  • Casas-Torremocha, Diana
  • Manasanch, Arnau
  • Dalla Porta, Leonardo
  • Gosseries, Olivia
  • Alnagger, Naji
  • Barra, Alice
  • Mejias, Jorge F.
  • Panda, Rajanikant
  • Riefolo, Fabio
  • Thibaut, Aurore
  • Bonhomme, Vincent
  • Thirion, Bertrand
  • Clasca, Francisco
  • Gorostiza, Pau
  • Sanchez-Vives, Maria V.
  • Deco, Gustavo
  • Laureys, Steven
  • Zamora-López, Gorka
  • Annen, Jitka
Experimental and clinical studies of consciousness identify brain states (i.e. quasi-stable functional cerebral organization) in a non-systematic manner and largely independent of the research into brain state modulation. In this narrative review, we synthesize advances in the identification of brain states associated with consciousness in animal models and physiological (sleep), pharmacological (anaesthesia) and pathological (disorders of consciousness) states of altered consciousness in humans. We show that in reduced consciousness the frequencies in which the brain operates are slowed down and that the pattern of functional communication is sparser, less efficient, and less complex. The results also highlight damaged resting-state networks, in particular the default mode network, decreased connectivity in long-range connections and especially in the thalamocortical loops. Next, we show that therapeutic approaches to treat disorders of consciousness, through pharmacology (e.g. amantadine, zolpidem), and (non-) invasive brain stimulation (e.g. transcranial direct current stimulation, deep brain stimulation) have shown partial effectiveness in promoting consciousness recovery. Although some features of conscious brain states may improve in response to neuromodulation, targeting often remains non-specific and does not always lead to (behavioural) improvements. The fields of brain state identification and neuromodulation of brain states in relation to consciousness are showing fascinating developments that, when integrated, might propel the development of new and better-targeted techniques for disorders of consciousness. We here propose a therapeutic framework for the identification and modulation of brain states to facilitate the interaction between the two fields. We propose that brain states should be identified in a predictive setting, followed by theoretical and empirical testing (i.e. in animal models, under anaesthesia and in patients with a disorder of consciousness) of neuromodulation techniques to promote consciousness in line with such predictions. This framework further helps to identify where challenges and opportunities lay for the maturation of brain state research in the context of states of consciousness. It will become apparent that one angle of opportunity is provided through the addition of computational modelling. Finally, it aids in recognizing possibilities and obstacles for the clinical translation of these diagnostic techniques and neuromodulation treatment options across both the multimodal and multi-species approaches outlined throughout the review., NA is research fellow, OG and AT are Research Associates, and SL is the research director at Fonds de la Recherche Scientifique (FRS-FNRS). JA is a postdoctoral fellow at the Fonds voor Wetenschappelijk Onderzoek (FWO) (1265522N). The study was further supported by the University and University Hospital of Liège, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the FNRS PDR project (T.0134.21), the ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project), the fund Generet, the King Baudouin Foundation, the Télévie Foundation, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PROgramme de Développement d'Expériences scientifiques (PRODEX Programme), the Public Utility Foundation `Université Européenne du Travail', `Fondazione Europea di Ricerca Biomedica', the BIAL Foundation, the Mind Science Foundation, the European Commission, the Fondation Leon Fredericq, the Mind-Care foundation, the DOCMA project (EU-H2020-MSCA-RISE-778234), the National Natural Science Foundation of China (Joint Research Project 81471100) and the European Foundation of Biomedical Research (FERB Onlus). EU grants ICT-36-2020-101016787 (DEEPER), EIC Pathfinder GAP-101130883 (PHOTOTHERAPORT), and -EIC-2023-PATHFINDEROPEN-101130650 (META-BRAIN), Government of Catalonia AGAUR [Centres de Recerca de Catalunya (CERCA) Programme, 2021-SGR-01410; AGAUR 2021-SGR-01165 - NEUROVIRTUAL], Ministerio de Ciencia e Innovación (MICINN) grants PID2019-111493RB-I00 (DEEP RED) and PID2022- 142609OB-I00 (EPILLUM), PID2020-112947RB-I00 financed by Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)/10.13039/501100011033 (CORTICOMOD), and Fundaluce and 'la Caixa' foundations (ID 100010434, agreement LCF/PR/HR19/52160010).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Subunit-specific photocontrol of glycine receptors by azobenzene-nitrazepam photoswitcher

  • Maleeva, Galeena
  • König, Burkhard
  • Gorostiza Langa, Pablo Ignacio
  • Nin Hill, Alba
  • Rustler, Karin
  • Petukhova, Elena
  • Ponomareva, Daria
  • Gomila Juaneda, Alexandre
  • Wutz, Daniel
  • Bregestovski, Piotr
  • Alfonso Prieto, Mercedes
© 2021 Maleeva et al. Photopharmacology is a unique approach that through a combination of photochemistry methods and advanced life science techniques allows the study and control of specific biological processes, ranging from intracellular pathways to brain circuits. Recently, a first photochromic channel blocker of anion-selective GABAA receptors, the azobenzene-nitrazepam-based photochromic compound (Azo-NZ1), has been described. In the present study, using patch-clamp technique in heterologous system and in mice brain slices, site-directed mutagenesis and molecular modeling we provide evidence of the interaction of Azo-NZ1 with glycine receptors (GlyRs) and determine the molecular basis of this interaction. Glycinergic synaptic neurotransmission determines an important inhibitory drive in the vertebrate nervous system and plays a crucial role in the control of neuronal circuits in the spinal cord and brain stem. GlyRs are involved in locomotion, pain sensation, breathing, and auditory function, as well as in the development of such disorders as hyperekplexia, epilepsy, and autism. Here, we demonstrate that Azo-NZ1 blocks in a UV-dependent manner the activity of a2 GlyRs (GlyR2), while being barely active on a1 GlyRs (GlyR1). The site of Azo-NZ1 action is in the chloride-selective pore of GlyR at the 2’ position of transmembrane helix 2 and amino acids forming this site determine the difference in Azo-NZ1 blocking activity between GlyR2 and GlyR1. This subunit-specific modulation is also shown on motoneurons of brainstem slices from neonatal mice that switch during development from expressing “fetal” GlyR2 to “adult” GlyR1 receptors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Control of Brain State Transitions with a Photoswitchable Muscarinic Agonist

  • Barbero-Castillo, Almudena|||0000-0003-0056-2348
  • Riefolo, Fabio|||0000-0002-6762-2619
  • Matera, Carlo|||0000-0001-6939-3859
  • Caldas-Martínez, Sara|||0000-0003-2527-2056
  • Mateos-Aparicio Moreno, Pedro|||0000-0001-8513-4005
  • Weinert, Julia F.|||0000-0003-4413-7212
  • Garrido-Charles, Aida
  • Claro Izaguirre, Enrique|||0000-0002-7592-7906
  • Sánchez Vives, María V.|||0000-0002-8437-9083
  • Gorostiza, Pau|||0000-0002-7268-5577
The ability to control neural activity is essential for research not only in basic neuroscience, as spatiotemporal control of activity is a fundamental experimental tool, but also in clinical neurology for therapeutic brain interventions. Transcranial-magnetic, ultrasound, and alternating/direct current (AC/DC) stimulation are some available means of spatiotemporal controlled neuromodulation. There is also light-mediated control, such as optogenetics, which has revolutionized neuroscience research, yet its clinical translation is hampered by the need for gene manipulation. As a drug-based light-mediated control, the effect of a photoswitchable muscarinic agonist (Phthalimide-Azo-Iper (PAI)) on a brain network is evaluated in this study. First, the conditions to manipulate M2 muscarinic receptors with light in the experimental setup are determined. Next, physiological synchronous emergent cortical activity consisting of slow oscillations-as in slow wave sleep-is transformed into a higher frequency pattern in the cerebral cortex, both in vitro and in vivo, as a consequence of PAI activation with light. These results open the way to study cholinergic neuromodulation and to control spatiotemporal patterns of activity in different brain states, their transitions, and their links to cognition and behavior. The approach can be applied to different organisms and does not require genetic manipulation, which would make it translational to humans. Brain pathologies often require drug treatments, however drugs act all over the central nervous system. Wouldn't it be good to determine where/when a drug should be active? Drugs can be made sensitive to light, to be activated at specific times and locations. This study demonstrates that a light-activated cholinergic drug can effectively modulate activity in the cerebral cortex network.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Adrenergic Modulation With Photochromic Ligands

  • Prischich, Davia|||0000-0001-6669-0436
  • Gomila, Alexandre|||0000-0003-0867-6171
  • Milla-Navarro, Santiago|||0000-0002-6947-5034
  • Sangüesa, Gemma|||0000-0002-6902-4372
  • Diez Alarcia, Rebeca|||0000-0002-0806-9825
  • Preda, Beatrice
  • Matera, Carlo|||0000-0001-6939-3859
  • Batlle, Montserrat|||0000-0002-3034-2023
  • Ramírez, Laura
  • Giralt, Ernest|||0000-0001-8381-1797
  • Hernando, Jordi|||0000-0002-1126-4138
  • Guasch, Eduard|||0000-0003-4238-5319
  • Meana, J. Javier|||0000-0002-7913-6714
  • de la Villa, Pedro|||0000-0001-9856-6616
  • Gorostiza, Pau|||0000-0002-7268-5577
Adrenoceptors are ubiquitous and mediate important autonomic functions as well as modulating arousal, cognition, and pain on a central level. Understanding these physiological processes and their underlying neural circuits requires manipulating adrenergic neurotransmission with high spatio-temporal precision. Here we present a first generation of photochromic ligands (adrenoswitches) obtained via azologization of a class of cyclic amidines related to the known ligand clonidine. Their pharmacology, photochromism, bioavailability, and lack of toxicity allow for broad biological applications, as demonstrated by controlling locomotion in zebrafish and pupillary responses in mice.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals

  • Matera, Carlo|||0000-0001-6939-3859
  • Calvé, Pablo
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • Sortino, Rosalba|||0000-0002-8854-6782
  • Gomila, Alexandre|||0000-0003-0867-6171
  • Moreno, Estefanía|||0000-0002-2491-5753
  • Gener, Thomas Adrien|||0000-0001-9209-9228
  • Delgado-Sallent, Cristina|||0000-0002-2202-1043
  • Nebot, Pau
  • Costazza, Davide|||0000-0002-7876-0291
  • Conde Berriozabal, Sara|||0000-0002-3712-8046
  • Masana, Mercè|||0000-0003-1392-4774
  • Hernando, Jordi|||0000-0002-1126-4138
  • Casadó, Vicent|||0000-0002-1764-3825
  • Puig Velasco, Maria Victoria|||0000-0002-1490-4153
  • Gorostiza, Pau|||0000-0002-7268-5577
Understanding the dopaminergic system is a priority in neurobiology and neuropharmacology. Dopamine receptors are involved in the modulation of fundamental physiological functions, and dysregulation of dopaminergic transmission is associated with major neurological disorders. However, the available tools to dissect the endogenous dopaminergic circuits have limited specificity, reversibility, resolution, or require genetic manipulation. Here, we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control of dopaminergic transmission. We demonstrate that azodopa activates D1-like receptors in vitro in a light-dependent manner. Moreover, it enables reversibly photocontrolling zebrafish motility on a timescale of seconds and allows separating the retinal component of dopaminergic neurotransmission. Azodopa increases the overall neural activity in the cortex of anesthetized mice and displays illumination-dependent activity in individual cells. Azodopa is the first photoswitchable dopamine agonist with demonstrated efficacy in wild-type animals and opens the way to remotely controlling dopaminergic neurotransmission for fundamental and therapeutic purposes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Fast Photoswitchable Molecular Prosthetics Control Neuronal Activity in the Cochlea

  • Garrido Charles, Aida|||0000-0002-9577-6682
  • Huet, Antoine|||0000-0001-6151-7183
  • Matera, Carlo|||0000-0001-6939-3859
  • Thirumalai, Anupriya|||0000-0002-3624-0343
  • Hernando, Jordi|||0000-0002-1126-4138
  • Llebaria, Amadeu|||0000-0002-8200-4827
  • Moser, Tobias|||0000-0001-7145-0533
  • Gorostiza, Pau|||0000-0002-7268-5577
Artificial control of neuronal activity enables the study of neural circuits and restoration of neural functions. Direct, rapid, and sustained photocontrol of intact neurons could overcome the limitations of established electrical stimulation such as poor selectivity. We have developed fast photoswitchable ligands of glutamate receptors (GluRs) to enable neuronal control in the auditory system. The new photoswitchable ligands induced photocurrents in untransfected neurons upon covalently tethering to endogenous GluRs and activating them reversibly with visible light pulses of a few milliseconds. As a proof of concept of these molecular prostheses, we applied them to the ultrafast synapses of auditory neurons of the cochlea that encode sound and provide auditory input to the brain. This drug-based method afforded the optical stimulation of auditory neurons of adult gerbils at hundreds of hertz without genetic manipulation that would be required for their optogenetic control. This indicates that the new photoswitchable ligands are also applicable to the spatiotemporal control of fast spiking interneurons in the brain.